These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28850195)

  • 21. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay.
    Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M
    Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Threshold value of LIAISON XL anti-HCV screening assay predicting positive immunoblotting results.
    De Paschale M; Manco MT; Arpino O; Ricucci V; Paganini A; Belvisi L; Cagnin D; Cerulli T; Cianflone A; Agrappi C; Mirri P; Clerici P
    J Med Virol; 2017 Oct; 89(10):1817-1822. PubMed ID: 28401710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of a strategy for HCV antibody testing with two enzyme immunoassays in a routine clinical laboratory.
    Vermeersch P; Van Ranst M; Lagrou K
    J Clin Virol; 2008 Aug; 42(4):394-8. PubMed ID: 18448386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
    Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
    Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure.
    Bes M; Esteban JI; Casamitjana N; Piron M; Quer J; Cubero M; Puig L; Guardia J; Sauleda S
    Transfusion; 2009 Jul; 49(7):1296-305. PubMed ID: 19222816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
    Bruhn R; Lelie N; Busch M; Kleinman S;
    Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serological and molecular genetic markers of hepatitis C virus in infected donors].
    Zubkova NV; Filatova EV; Zubov SV
    Vopr Virusol; 2010; 55(5):34-6. PubMed ID: 21260994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
    Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
    Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
    Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
    Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
    Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved detection of hepatitis C virus-positive blood donors and determination of infection status.
    Nishiya AS; de Almeida-Neto C; Witkin SS; Ferreira SC; Salles NA; Nogueira FAH; Oliveira CDL; Rocha V; Mendrone Júnior A
    Transfus Med; 2023 Apr; 33(2):159-164. PubMed ID: 36251615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HCV RNA testing for early diagnosis of hepatitis C in blood donors--new challenge for transfusion medicine and hepatology].
    Brojer E; Letowska M; Gronowska A; Kubicka-Russel D; Liszewski G; Grabarczyk P; Medyńska J; Mikulska K; Sabliński J
    Pol Merkur Lekarski; 2004 Oct; 17(100):321-5. PubMed ID: 15690692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Follow-up of blood donors with positive serology for hepatitis C virus and their recipients is insufficient].
    Bonaguidi-Magniaux M; Pilette C; Oberti F; Bidet ML; Calès P
    Gastroenterol Clin Biol; 1996; 20(8-9):663-8. PubMed ID: 8977814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection.
    Laperche S; Le Marrec N; Girault A; Bouchardeau F; Servant-Delmas A; Maniez-Montreuil M; Gallian P; Levayer T; Morel P; Simon N
    J Clin Microbiol; 2005 Aug; 43(8):3877-83. PubMed ID: 16081925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.